CareTrust REIT Announces Third Quarter 2026 Operating Results; Updates 2026 Guidance

CareTrust REIT reported Q3 2026 net income of $83.7M, with normalized FFO and FAD per share up 20% YoY. The company acquired 45 U.K. care homes for £1.1B and raised 2026 guidance. It maintains a quarterly dividend of $0.39 per share. CareTrust has $2B in liquidity and a Net Debt-to-EBITDA ratio of 1.4x.

Original reporting
Published Nov 5, 2026, 9:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 9:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CTRE
Bullish
high confidence
Mentioned
$CTRE
Relevance
8/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CTREBullishHigh
01

Why it matters

The earnings beat and guidance lift provide fresh, material information for investors, likely prompting buying pressure.

02

Market read

First report of Q3 results and guidance raise; material for REIT and dividend‑focused investors.

03

What to watch

Potential risks from UK acquisition execution and currency exposure (GBP/USD) could temper upside.

Relevance 8/10Novelty 8/10Timing: today after earnings release

Background

CareTrust REIT announced Q3 2026 earnings, net income, normalized FFO/FAD, a quarterly dividend, and updated 2026 guidance, plus a UK care‑home acquisition.

Company-level read

Ticker impact

$CTREBullishHigh confidence
Context

CareTrust REIT released Q3 2026 results and raised full-year guidance, providing new earnings and dividend information.

Expected impact

upward pressure as investors price in higher FFO and dividend outlook

Evidence & confidence

The company beat prior expectations, increased normalized FFO/FAD, and lifted guidance, which typically drives buying.

Market effects

Higher guidance may boost sentiment for the healthcare REIT sector.

US REIT market may see modest gains.

Limited to REIT investors; no broader macro impact.

Counterpoint

If the guidance raise is already priced in, the stock could face a short‑term pull‑back.

Key entities

  • CareTrust REIT

    Publicly‑traded REIT focused on senior housing and healthcare properties.

  • Dave Sedgwick

    CEO of CareTrust REIT who commented on the results.

Related articles

$CTREMed

CareTrust REIT: Q3 Earnings Snapshot

CareTrust REIT (CTRE) reported Q3 funds from operations of $127M, or 54c/share, exceeding analysts' 52c/share estimate. Revenue was $176.4M, surpassing the $171M forecast. The company projects full-year FFO between $2.08 and $2.09 per share.

$CTREHighAI 8/10

CareTrust REIT Announces Third Quarter 2026 Operating Results; Updates 2026 Guidance Conference Call Scheduled for Friday, November 6, 2026 at 11:00 am ET

CareTrust REIT, Inc. (CTRE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CareTrust REIT Announces Third Quarter 2026 Operating Results; Updates 2026 Guidance Conference Call Scheduled for Friday, November 6, 2026 at 11:00 am ET DANA POINT, Calif., November 5, 2026 (BUSINESS WIRE) -- CareTrust REIT, Inc. (NYSE:CTRE) today reported operatin

$CTREMed

JPMorgan initiates CareTrust REIT stock coverage with neutral rating

JPMorgan initiated coverage on CareTrust REIT (CTRE) with a Neutral rating and a $41.00 price target for 2027, citing strong earnings growth and acquisition activity. Revenue surged 53% to $571 million over the last year. The company is expanding into the UK and senior housing, with recent acquisitions totaling $1.9 billion. Analysts have mixed price targets, ranging from $42 to $46.

$CTREMedAI 8/10

CareTrust REIT stock rating maintained at outperform by Citizens

Citizens maintained a Market Outperform rating and $44.00 price target on CareTrust REIT (CTRE) following its $1.4B acquisition of 45 UK care homes. CTRE trades at $36.64, with analysts citing potential upside. The REIT has a 4.26% dividend yield and a 'GREAT' financial health score of 3.45/5. Other analysts have mixed price targets, ranging from $42 to $47.